PMID: 38458701
Whats the Buzz The Bee Healthy Blog BuzzRx State of Our Health Report: July 2024 BuzzRx compiled national medication insights from Jan 1, 2023, to the present, providing an in-depth analysis of emerging trends in prescriptions filled across the country and the implications these patterns may have on public health
Bruce, its more complicated than that it depends in the comorbidities conditions, if an SLGT is recommended as well
In summary, semaglutide has proven to be a pinnacle of GLP-1 drug development so far: highly efficacious for glycemic control, capable of inducing substantial weight loss, and demonstrating broad benefits (cardiovascular, renal, and beyond)
This hormone helps break down stored fat (lipolysis) to provide energy to your body, which leads to weight loss